KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cme (CME) Gross Margin (2016 - 2025)

Historic Gross Margin for Cme (CME) over the last 17 years, with Q3 2025 value amounting to 96.42%.

  • Cme's Gross Margin rose 3500.0% to 96.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 96.05%, marking a year-over-year increase of 6600.0%. This contributed to the annual value of 95.63% for FY2024, which is 5800.0% up from last year.
  • Per Cme's latest filing, its Gross Margin stood at 96.42% for Q3 2025, which was up 3500.0% from 96.86% recorded in Q2 2025.
  • Over the past 5 years, Cme's Gross Margin peaked at 96.86% during Q2 2025, and registered a low of 92.13% during Q4 2022.
  • Its 5-year average for Gross Margin is 95.41%, with a median of 95.81% in 2023.
  • As far as peak fluctuations go, Cme's Gross Margin surged by 17700bps in 2021, and later tumbled by -8100bps in 2022.
  • Cme's Gross Margin (Quarter) stood at 92.95% in 2021, then decreased by -1bps to 92.13% in 2022, then rose by 1bps to 92.92% in 2023, then rose by 1bps to 94.07% in 2024, then increased by 2bps to 96.42% in 2025.
  • Its last three reported values are 96.42% in Q3 2025, 96.86% for Q2 2025, and 96.69% during Q1 2025.